22 April 2005 Final Programme - The British Society for Rheumatology
22 April 2005 Final Programme - The British Society for Rheumatology
22 April 2005 Final Programme - The British Society for Rheumatology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
109 REGULATORY ROLE OF CCL21 IN THE RECRUITMENT AND EXIT OF IMMUNE CELLS IN<br />
RHEUMATOID SYNOVIUM.<br />
A. Manzo 1 , S. Bugatti 2 , C. Buckley 3 , D. Jackson 4 , R. Caporali 2 , C. Montecucco 2 , C. Pitzalis 1<br />
1<br />
<strong>Rheumatology</strong> Unit, GKT School of Medicine, London, United Kingdom; 2 Cattedra di Reumatologia,<br />
IRCCS Policlinico S.Matteo, Pavia, Italy; 3 Department of <strong>Rheumatology</strong>, Birmingham University,<br />
Birmingham, United Kingdom; 4 Institute <strong>for</strong> Molecular Medicine, John Radcliffe Hospital, Ox<strong>for</strong>d,<br />
United Kingdom<br />
110 INCREASED CD161 mRNA EXPRESSION IN PERIPHERAL BLOOD CD4 + T LYMPHOCYTES<br />
IDENTIFIES RHEUMATOID ARTHRITIS PATIENTS UNLIKELY TO DEVELOP EROSIONS.<br />
H. Kamrova 1 , R.J. Moots 1,2 , J. Dawson 3 , R.N. Thompson 2 , E. Williams 2 , L. Pazmany 1<br />
1<br />
Department of Medicine, University of Liverpool, Liverpool, Merseyside, United Kingdom;<br />
2<br />
Department of <strong>Rheumatology</strong>, University Hospital Aintree, Liverpool, Merseyside, United Kingdom;<br />
3<br />
Department of <strong>Rheumatology</strong>, St Helen's and Whiston Hospital, Whiston, Merseyside, United<br />
Kingdom<br />
111 REGULATORY T CELL DEFECT IN THE ARTHRITIS-SUSCEPTIBLE DBA/1 MOUSE.<br />
S.P. Fairchild 1 , M. Schenk 1 , R. Doffinger 2 , F.C. Hall 1<br />
1<br />
Department of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom;<br />
2<br />
Department of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge,<br />
United Kingdom<br />
Rheumatoid arthritis – treatment<br />
112 METHOTREXATE INDUCED PANCYTOPENIA -SERIOUS AND UNDER RECORDED?<br />
OUR EXPERIENCE OF 25 PATIENTS IN 5 YEARS.<br />
A.Y.N. Lim, K. Gaffney, D.G.I. Scott<br />
<strong>Rheumatology</strong>, Norfolk and Norwich University Hospital, Norwich, United Kingdom<br />
113 SHOULD THE MONITORING OF METHOTREXATE AND LEFLUNOMIDE BE THE SAME?<br />
S. Rajakulendran, D. Allen, C. Deighton<br />
Department of <strong>Rheumatology</strong>, Derbyshire Royal Infirmary, Derby, Derbyshire, United Kingdom<br />
114 A COMPARISON OF THE ADVICE GIVEN FOR ALCOHOL CONSUMPTION IN PATIENTS<br />
TAKING METHOTREXATE AND LEFLUNOMIDE.<br />
S. Rajakulendran, C. Deighton<br />
Department of <strong>Rheumatology</strong>, Derbyshire Royal Infirmary, Derby, Derbyshire, United Kingdom<br />
115 NO DIFFERENCE IN OUTCOME BETWEEN SULFASALAZINE OR METHOTREXATE AS THE<br />
FIRST DMARD IN PATIENTS WITH INFLAMMATORY POLYARTHRITIS.<br />
S.L. Hider, M. Lunt, S. Manning, D. Bunn, A. Silman, D. Symmons<br />
ARC Epidemiology Unit, University of Manchester, Manchester, United Kingdom; Norfolk Arthritis<br />
Register, Norwich, United Kingdom<br />
116 SCREENING FOR LUNG DISEASE PRIOR TO METHOTREXATE IN RHEUMATOID ARTHRITIS.<br />
A. Dixit, V. Saravanan, C.A. Kelly<br />
Department of <strong>Rheumatology</strong> and Medicine, Queen Elizabeth Hospital, Gateshead, Tyne & Wear,<br />
United Kingdom<br />
117 CLINICAL AUDIT: DOES THE MONITORING OF METHOTREXATE THERAPY MEET THE<br />
DEPARTMENTAL GUIDELINES?<br />
R.W. Marshall, A. Wood, R.G. Hull, J.M. Ledingham, F.C. McCrae, R. Shaban, A.L. Thomas,<br />
K.R. MacKay<br />
<strong>Rheumatology</strong>, Queen Alexandra Hospital, Cosham, Portsmouth, United Kingdom<br />
47
Change language